Table 5. Pro- and anti-coagulation factors for patients with and without hemorrhage in the NC-PVT group.
| Variables | Hemorrhage (n = 39) | Non-hemorrhage (n = 35) | P value |
|---|---|---|---|
| Factor II, % | 81.1 ± 16.2 | 84.9 ± 28.2 | 0.588 |
| Factor V, % | 70.2± 30.4 | 76.4 ± 32.9 | 0.506 |
| Factor VII, % | 72.7± 20.1 | 80.7 ± 33.9 | 0.353 |
| Factor VIII, % | 152.7 ± 73.1 | 163.1 ± 78.4 | 0.647 |
| Factor IX, % | 71.1 ± 19.5 | 87.1 ± 31.6 | 0.060 |
| Factor X, % | 63.7 ± 16.9 | 74.2 ± 25.9 | 0.124 |
| Factor XI, % | 65.1 ± 32.7 | 69.8 ± 26.3 | 0.584 |
| Factor XII, % | 52.5 ± 20.6 | 53.7 ± 28.8 | 0.858 |
| PC, % | 69.1 ± 20.8 | 74.2 ± 30.5 | 0.486 |
| PS, % | 64.5 ± 17.6 | 68.6 ± 29.6 | 0.555 |
| AT, % | 72.9 ± 16.0 | 77.2 ± 21.6 | 0.398 |
NOTE. Values are expressed as mean ± SD.
Abbreviations: AT, antithrombin; PC, protein C; PS, protein S; NC-PVT, non-cirrhotic non-tumoral portal vein thrombosis.